These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22367656)

  • 21. Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a randomized, double-blind, placebo-controlled trial.
    van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Olderikkert MG; Beekman AT; de Groot LC
    J Am Geriatr Soc; 2009 Aug; 57(8):1481-6. PubMed ID: 19549020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia.
    Emsley R; Chiliza B; Asmal L; du Plessis S; Phahladira L; van Niekerk E; van Rensburg SJ; Harvey BH
    Schizophr Res; 2014 Sep; 158(1-3):230-5. PubMed ID: 24996507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
    Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis.
    Veerman SR; Schulte PF; Begemann MJ; de Haan L
    Pharmacopsychiatry; 2014 Nov; 47(7):231-8. PubMed ID: 25121994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.
    Bentsen H; Osnes K; Refsum H; Solberg DK; Bøhmer T
    Transl Psychiatry; 2013 Dec; 3(12):e335. PubMed ID: 24346133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: Possible stage-specific effects.
    Chen AT; Chibnall JT; Nasrallah HA
    Ann Clin Psychiatry; 2015 Nov; 27(4):289-96. PubMed ID: 26554370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of Brief Psychotic Episodes: A Meta-analysis.
    Fusar-Poli P; Cappucciati M; Bonoldi I; Hui LM; Rutigliano G; Stahl DR; Borgwardt S; Politi P; Mishara AL; Lawrie SM; Carpenter WT; McGuire PK
    JAMA Psychiatry; 2016 Mar; 73(3):211-20. PubMed ID: 26764163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-randomized open trial of eicosapentaenoic acid (EPA), an omega-3 fatty acid, in ten people with chronic epilepsy.
    Yuen AW; Flugel D; Poepel A; Bell GS; Peacock JL; Sander JW
    Epilepsy Behav; 2012 Mar; 23(3):370-2. PubMed ID: 22342198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regression.
    Velthorst E; Koeter M; van der Gaag M; Nieman DH; Fett AK; Smit F; Staring AB; Meijer C; de Haan L
    Psychol Med; 2015 Feb; 45(3):453-65. PubMed ID: 24993642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results.
    Peet M
    Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):477-85. PubMed ID: 14623502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies.
    Fusar-Poli P; Meyer-Lindenberg A
    Schizophr Bull; 2013 Jan; 39(1):33-42. PubMed ID: 22282454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cariprazine for treating psychosis: an updated meta-analysis.
    Generoso MB; Taiar I; Cordeiro Q; Shiozawa P; Kasper S
    Int J Psychiatry Clin Pract; 2023 Mar; 27(1):107-109. PubMed ID: 35544479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical potential of omega-3 fatty acids in the treatment of schizophrenia.
    Emsley R; Oosthuizen P; van Rensburg SJ
    CNS Drugs; 2003; 17(15):1081-91. PubMed ID: 14661986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study.
    Berger GE; Wood SJ; Wellard RM; Proffitt TM; McConchie M; Amminger GP; Jackson GD; Velakoulis D; Pantelis C; McGorry PD
    Neuropsychopharmacology; 2008 Sep; 33(10):2467-73. PubMed ID: 18199999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. omega-3 Fatty acid for schizophrenia.
    Horrobin DF
    Am J Psychiatry; 2003 Jan; 160(1):188-9; author reply 189. PubMed ID: 12505833
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of mind-body and aerobic exercise on negative symptoms in schizophrenia: A meta-analysis.
    Vogel JS; van der Gaag M; Slofstra C; Knegtering H; Bruins J; Castelein S
    Psychiatry Res; 2019 Sep; 279():295-305. PubMed ID: 30879703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen augmentation in schizophrenia: a quantitative review of current evidence.
    Begemann MJ; Dekker CF; van Lunenburg M; Sommer IE
    Schizophr Res; 2012 Nov; 141(2-3):179-84. PubMed ID: 22998932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study.
    Wood SJ; Cocchi L; Proffitt TM; McConchie M; Jackson GD; Takahashi T; Pantelis C; McGorry PD; Berger GE
    Psychiatry Res; 2010 May; 182(2):180-2. PubMed ID: 20413278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis.
    Fraguas D; Díaz-Caneja CM; Pina-Camacho L; Umbricht D; Arango C
    Schizophr Bull; 2019 Jan; 45(1):57-68. PubMed ID: 29370436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of ethyl-EPA as a treatment for Huntington disease: a systematic review and meta-analysis.
    Morsy S; Khalil SM; Doheim MF; Kamel MG; El-Basiony DSM; Ahmed Hassan HI; Eisa AA; Anh Ngoc CT; Dang NP; Hirayama K; Huy NT
    Acta Neuropsychiatr; 2019 Aug; 31(4):175-185. PubMed ID: 30890195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.